Aspirin versus placebo in stage III or high-risk stage II colon cancer with PIK3CA mutation: A French randomised double-blind phase III trial (PRODIGE 50-ASPIK)

Autor: Michel, Pierre, Boige, Valerie, Andre, Thierry, Aparicio, Thomas, Bachet, Jean Baptiste, Dahan, Laetitia, Guimbaud, Rosine, Lepage, Côme, Manfredi, Sylvain, Tougeron, David, Taieb, Julien, Selves, Janick, Le Malicot, Karine, Di Fiore, Frederic, Maillard, Emilie
Zdroj: In Digestive and Liver Disease March 2018 50(3):305-307
Databáze: ScienceDirect
Externí odkaz: